Trademark: TRI-ESTARYLLA
Put your brand on the blockchain and timestamp its proof of existence at wikitrademarks.io
Mark Identification
Proof of use for TRI-ESTARYLLA
We do not have any records of a proof of use for TRI-ESTARYLLA at this moment.
Possible trademark infringements of TRI-ESTARYLLA
Basic Information about TRI-ESTARYLLA
- Serial Number
- 85196127
- Filing Date
- 13 Dec 2010
- Registration Number
- 4403689
- Registration Date
- 17 Sep 2013
- Mark Drawing Code
- 4
Classifications
Declare the trademark use of TRI-ESTARYLLA on the blockchain with WikiTrademarks.io.
- First use of TRI-ESTARYLLA anywhere
- TRI-ESTARYLLA was first used on 18 Mar 2013 for the primary classification of goods and services, international, 005 (Pharmaceuticals)
- First use in commerce
- There is no first use of this trademark in commerce detected yet.
- Status Code
- 6
- International Code
- 005
- US Codes
- 006; 018; 044; 046; 051; 052
Who owns TRI-ESTARYLLA?
1. XIROMED PHARMA ESPAÑA S.L. MADRID
2. LABORATORIOS LEÓN FARMA, S.A. 24008 LEÓN
3. Novartis AG Basel
4. Novartis AG Basel
5. Novartis AG Basel
Correspondent
- Vivian Ortiz-Ponce
- PEREZ GUERRERO LLC
- P.O. Box 9024163
- San Juan,PR 00902-4163
Put your brand on the blockchain and timestamp its proof of existence at Wikitrademarks.io